Skip to content
DraconiticResearch
Search Sources API
186,625 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC 4.0Asian Pacific Journal of Cancer Prevention : APJCP

Gut Microbiota Modulation via Synbiotics: A Perspective for Boosting Antitumor Immunity and Inactivating Carcinogens in Early Life

4 affiliations
  1. 1Department of Biomedicine and Biochemistry, Universitas Muhammadiyah Surabaya, Surabaya, Indonesia.
  2. 2Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia.
  3. 3Department of Medicine, Faculty of Medicine, University YARSI, DKI Jakarta, Indonesia.
  4. 4Department of Urology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

Abstract

Objective:: Children are highly susceptible to infections and long-term health risks due to their immature immune systems, which typically develop fully around the age of 12. While early infections generate T and B memory cells, establishing a robust immune foundation is crucial not only for combating pathogens but also for preventing carcinogenesis in later life. Synbiotics, a synergistic combination of probiotics and prebiotics, offer a promising strategy to modulate the gastrointestinal microenvironment.

Method:: This article proposes that synbiotic supplementation provides dual benefits: enhancing immediate immunity and offering potential chemopreventive effects.

Result:: Mechanistically, synbiotics maintain microbial balance (increasing Lactobacillus and Bifidobacterium), which leads to (1) increased production of artificial endogenous immunoglobulins like IgG to neutralize toxins and pathogens; (2) inactivation of cancer-causing chemicals and reduction of unwanted metabolite concentrations; and (3) enhancement of Natural Killer (NK) cell activity and antioxidant capacity, which are vital for tumor surveillance and reducing oxidative stress. By modulating the gut microbiota, synbiotics not only boost IgG levels to prevent common infections but also strengthen the body’s defense against mutagenic agents.

Conclusion:: This opinion article summarizes clinical and preclinical findings to highlight the efficacy of synbiotics as a comprehensive immune booster and a potential agent for early cancer prevention strategies.

Related

  1. Targeted Modulation of Gut Microbiota: A New Perspective on Acupuncture for the Treatment of Knee Osteoarthritis.
    Wenwen Duan, Wei Zhang, Ning Wei +5
    Journal of pain researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. P2226 alleviates respiratory inflammation and depression related behaviors with modulation of cytokines and gut microbiota in mice
    Hee-Seo Park, Hyo-Min Jang, Xiaoyang Ma +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyCrossref
  3. Intestinal Responses to Short-Term Hexaflumuron Exposure in Grass Carp (Ctenopharyngodon idella): A Combined Physiological, Transcriptomic, and Gut Microbiota Perspective.
    Shun Zhou, Jiangtao Li, Qiuhong Yang +1
    Animals : an open access journal from MDPIPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Immunomodulatory mechanisms of gut microbiota-derived metabolites in non-small cell lung cancer: a gut–lung axis perspective
    Shumin Ye, Tian Tian, Junkang Huangfu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineFrontiersCrossrefDOAJ
  5. A case report on the pathogenesis of BAP1 inactivating melanocytomas (BIMTs).
    Alexander Michael Diaz, Lawrence Adam Schiffman, Evan Miller +1
    JAAD case reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
BibTeX
@article{lutfiana2026microbiota,
  title = {{Gut Microbiota Modulation via Synbiotics: A Perspective for Boosting Antitumor Immunity and Inactivating Carcinogens in Early Life}},
  author = {Nurul Cholifah Lutfiana and Adilla Shafryantyo Purnomo and Azzahra Syadza Nasywantya Purnomo and Athaya Febriantyo Purnomo},
  journal = {Asian Pacific Journal of Cancer Prevention : APJCP},
  year = {2026},
  month = jun,
  doi = {10.31557/apjcp.2026.27.6.2315},
  url = {https://doi.org/10.31557/apjcp.2026.27.6.2315},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Gut Microbiota Modulation via Synbiotics: A Perspective for Boosting Antitumor Immunity and Inactivating Carcinogens in Early Life
AU  - Nurul Cholifah Lutfiana
AU  - Adilla Shafryantyo Purnomo
AU  - Azzahra Syadza Nasywantya Purnomo
AU  - Athaya Febriantyo Purnomo
PY  - 2026
DA  - 2026/06/22
JO  - Asian Pacific Journal of Cancer Prevention : APJCP
DO  - 10.31557/apjcp.2026.27.6.2315
UR  - https://doi.org/10.31557/apjcp.2026.27.6.2315
AB  - Objective:: Children are highly susceptible to infections and long-term health risks due to their immature immune systems, which typically develop fully around the age of 12. While early infections generate T and B memory cells, establishing a robust immune foundation is crucial not only for combating pathogens but also for preventing carcinogenesis in later life. Synbiotics, a synergistic combination of probiotics and prebiotics, offer a promising strategy to modulate the gastrointestinal microenvironment.  Method:: This article proposes that synbiotic supplementation provides dual benefits: enhancing immediate immunity and offering potential chemopreventive effects.  Result:: Mechanistically, synbiotics maintain microbial balance (increasing Lactobacillus and Bifidobacterium), which leads to (1) increased production of artificial endogenous immunoglobulins like IgG to neutralize toxins and pathogens; (2) inactivation of cancer-causing chemicals and reduction of unwanted metabolite concentrations; and (3) enhancement of Natural Killer (NK) cell activity and antioxidant capacity, which are vital for tumor surveillance and reducing oxidative stress. By modulating the gut microbiota, synbiotics not only boost IgG levels to prevent common infections but also strengthen the body’s defense against mutagenic agents.  Conclusion:: This opinion article summarizes clinical and preclinical findings to highlight the efficacy of synbiotics as a comprehensive immune booster and a potential agent for early cancer prevention strategies.
SN  - 1513-7368
SN  - 2476-762X
ER  -